Swami Subramaniam

@airindia Great cabin, attentive service, ontime...what more can we ask for!

Flew @airindia from BLR to Mumbai. Lovely terminal, helpful onground and onboard staff, hot meal. #AIFans #FlyAI

WELCOME TO THE 4th MEETING IN THE SERIES OF RNA SpARC WEBINARS The mRNA Revolution: Key Patents and Legal Landscapes 14 December 2024 | 4:00 PM - 5:00 PM IST linkedin.com/feed/update/ur… @iiscbangalore @NCBS_Bangalore @swami2m

The pace of progress of AI in healthcare is mind boggling. The health sector is going to see a massive disruption within the next few years. For starters, the EMR as we know it today will be history, replaced by an AI medical record. Patients are going to be a lot more empowered than they are now. And a part of the decision making, especially in primary care, radiology, dermatology and some other specialties is going to be machine led. In India, the Medical community will fight tooth and nail and resist any introduction of AI into decision making, but change is coming and it is coming fast. They can adapt or be left behind in 5 years. Mark this post. #Healthcare #AI #AIinHealthcare #MEDTwitter

@sanjeevsanyal Industrial R&D takes root in publicly funded academic science. Can Palo Alto happen without Stanford. Can Cambridge MA innovate without Harvard. The parlous state of Indian academic science must be fixed for private companies to access inventions - the lifeblood of innovation!

We are now a US$4 trillion economy - and soon to be third largest in the world. Our business sector needs to show the same level of ambition. I speak and write often about the inadequacies of the organs of the Indian State, but this one must be on the private sector. Some rules may need changing, but this is inexcusable.

150% customs duty on lab chemicals. Who are we kidding about our commitment to innovation!

Why does healthcare not take to tech? linkedin.com/posts/swami2m_…

CALL FOR PROPOSALS ACORN-AMR FAST GRANTS 2023 (Round 2) for breakthrough solutions for antimicrobial resistance (AMR). Check this link for more details : ignitelsf.in/ACORN%20AMR%20… Email: swamis@ignitelsf.in.

In a comment published in IJME, @aranic et al propose that the N-of-1 trial be used as a practical method to evaluate Ayurvedic treatments. doi.org/10.20529/IJME.… @swami2m @amarjesani @sandhya19910 @HEaLInsti_FMES @VJ_PublicHealth @RamanathanMala

The N of 1 trial design can help validate traditional medicines. This will be good for patients and for traditional medicine. linkedin.com/posts/swami2m_…

tru dat

@IndiaBioscience @iiscbangalore @IISERPune @tvmiiser @RamonaParsani @hurryram @swami2m "Useful resource for anyone interested in cell and gene therapy: caringcross.org/archives/".

Ignite is keen to connect with Indian research faculty working on RNA therapeutics or vaccines. Pls DM me or send an email to swamis@ignitelsf.in @ignitelsf @sidjhunjhunwala Please RT

@HartoshSinghBal If he had been influenced by Gauss, Euler and Jacobi he would not have been Ramanujan. youtu.be/8eG2PfHte5g

On Ramanujan: Left to fend for himself at 16 by Carr, Ramanujan turned his compulsion into a virtue, arriving at mathematical truths through heuristic reasoning all his own. Imagine what he could've done if Gauss, Euler and Jacobi had been his guides. 3quarksdaily.com/3quarksdaily/2…

@manoj_naandi Hello, Manoj...how can reach you direct?

Now plant to human transmission of deadly disease 🤔💔 livemint.com/science/health…

Coming up soon! linkedin.com/posts/activity…

@DrSidMukherjee And here as well: shaastramag.iitm.ac.in/books/artful-s…

The Critics’ Picks: A Yea... - podcasts.apple.com/us/podcast/the… #iTunes

Branded generic medicines: A hydra-headed problem that slams the consumer while benefiting everyone else linkedin.com/posts/drswami_…